TRML

Tourmaline Bio, Inc. - Common Stock (TRML)

About Tourmaline Bio, Inc. - Common Stock (TRML)

Tourmaline Bio, Inc. is a late-stage clinical biotechnology company, which engages in the development of medicines for patients with life-altering immune diseases. It offers the TOUR006. The company was founded by Sandeep Kulkarni on September 17, 2021 and is headquartered in New York, NY.

Details

Daily high

$18.63

Daily low

$17.93

Price at open

$17.94

52 Week High

$29.79

52 Week Low

$11.56

Market cap

461.9M

Dividend yield

0.00%

Volume

24,428

Avg. volume

209,073

P/E ratio

-5.59

Tourmaline Bio, Inc. - Common Stock News